What Do PBMs Have To Hide? Max Theiler febrero 10, 2017 No hay comentarios The role of pharmacy benefit managers In US drug pricing. Read more
US Generics Price Increases Max Theiler enero 13, 2017 No hay comentarios A pill of wisdom. Read more
Twombly Or Not Twombly? Russell De Souza, CFA octubre 7, 2016 No hay comentarios Trends in US antitrust litigation. Read more
Drug Cartels In The USA Max Theiler agosto 28, 2016 No hay comentarios Could manufacturer drug cartels lead to higher generic drug prices? Read more
Closet Indexers Hiding Behind A High Active Share Russell De Souza, CFA julio 21, 2016 No hay comentarios The use of active share in identifying closet index funds. Read more
Event Studies – Pitfalls And Solutions Steffen Hennig julio 8, 2016 No hay comentarios Fideres launches online event study platform. Read more
Cross Holdings And Competition Alberto Thomas mayo 6, 2016 No hay comentarios Could highly concentrated holdings lead to anticompetitive behavior? Read more
Class Action Lawsuits And Stock Prices Steffen Hennig abril 21, 2016 No hay comentarios Insights from the Stanford clearinghouse. Read more
Robot Cartels Alberto Thomas marzo 18, 2016 No hay comentarios Algorithmic price fixing may be the new frontier of anti-trust. Read more
Collusion In The Interest Rate Swap (IRS) Market? Alberto Thomas noviembre 30, 2015 No hay comentarios Dodd-Frank reforms fail to stop interest rate price fixing. Read more
